alexa Atherogenic Dyslipidemia Scholarly Journal |omics Group|Journal Of Metabolic Syndrome

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Atherogenic Dyslipidemia Scholarly Journal 

Atherogenic dyslipidemia is a critical factor in developing CVD related to Metabolic Syndrome. While atherogenic dyslipidemia plays a prominent role in the development of atherosclerosis, endothelial dysfunction works alongside atherogenic dyslipidemia to contribute to the development of CVD as endothelial dysfunction also promotes atherosclerotic plaque development. This effect may provide to be synergistic in patients with MS, as endothelial dysfunction is predominantly found in this population. Other modes of action exist in MS which directly influence atherogenic dyslipidemia. Scholarly journal is a peer-reviewed journal in which scholarship relating to a particular academic discipline is published. Scholarly journals serve as forums for the introduction and presentation for scrutiny of new research, and the critique of existing research. Content typically takes the form of articles presenting original research, review articles, and book reviews.The term Scholarly journal applies to scholarly publications in all fields; this article discusses the aspects common to all academic field journals.
 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords